| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |